Stryker Corporation

SYK · NYSE · Stock · Healthcare
$280.27
-0.81% today
Delayed price,

What Stryker does

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Key facts

Sector
Healthcare
Industry
Medical Devices
Market cap
$107.50B
P/E (ttm)
29.0
Forward P/E
16.8
Dividend yield
1.25%
Beta
0.78
Profit margin
14.4%
Employees
56,000
Headquarters
Portage, MI, United States
Exchange
NYSE

Performance

1 Month
+1.9%
3 Months
-12.4%
6 Months
-18.4%
1 Year
-25.1%
5 Years
+18.4%
$267.0052-week range$392.55
Biggest setback — last 12 months
-29.7%
23 Feb 2026 → 21 Sept 2026
Fell from $387.46 to $272.36 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+18.8%
4 May 2026 → 10 Aug 2026
Ran from $285.47 to $339.21 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend
Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$255.40 (-8.9%)$280.27$307.56 (+9.7%)
3 Months$238.60 (-14.9%)$280.27$329.22 (+17.5%)
6 Months$223.21 (-20.4%)$280.27$351.91 (+25.6%)
12 Months$203.13 (-27.5%)$280.27$386.71 (+38.0%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 32.2%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.